Company Bio-Works Technologies AB (publ) Nasdaq Stockholm
Equities
SE0007387089
Medical Equipment, Supplies & Distribution
Business Summary
Sales per Business
SEK in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Agarose-based Chromatography Resins
100.0
%
| - | - | 44 | 100.0 % | - |
Sales per region
SEK in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Europe
72.1
%
| 20 | 48.2 % | 32 | 72.1 % | +59.08% |
North America
25.7
%
| 16 | 38.8 % | 11 | 25.7 % | -29.63% |
Asia
2.1
%
| 5 | 13.0 % | 1 | 2.1 % | -82.51% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Arne Hauge
DFI | Director of Finance/CFO | - | 23-07-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Peter Nählstedt
BRD | Director/Board Member | 50 | 20-05-14 |
Kirsti Gjellan
BRD | Director/Board Member | 61 | 18-05-17 |
Chairman | 69 | 19-09-08 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 38,979,790 | 19,052,993 ( 48.88 %) | 0 | 48.88 % |
Company contact information
Sector
Sales per Business
Sales per region
1st Jan change | Capi. | |
---|---|---|
-7.16% | 178B | |
-1.23% | 107B | |
-4.86% | 67.04B | |
-4.29% | 47.24B | |
+10.32% | 44.62B | |
+8.14% | 42.5B | |
+15.76% | 29.99B | |
+15.53% | 25.22B | |
-5.88% | 24.14B |